BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1871782)

  • 1. Regioselectivity of metabolic activation of acetylenic steroids by hepatic cytochrome P450 isozymes.
    Johnston JO; Wright CL; Leeson GA
    Steroids; 1991 Apr; 56(4):180-4. PubMed ID: 1871782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-activated inhibitors of steroidal hydroxylases.
    Johnston JO; Wright CL; Holbert GW
    J Steroid Biochem Mol Biol; 1995 Jan; 52(1):17-34. PubMed ID: 7857870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human trophoblast xenografts in athymic mice: a model for peripheral aromatization.
    Johnston JO; Wright CL; Shumaker RC
    J Steroid Biochem; 1989 Oct; 33(4A):521-9. PubMed ID: 2811362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.
    White IN; Muller-Eberhard U
    Biochem J; 1977 Jul; 166(1):57-64. PubMed ID: 901418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destruction of cytochrome P-450 and formation of green pigments by contraceptive steroids in rat hepatocyte suspensions.
    Blakey DC; White IN
    Biochem Pharmacol; 1986 May; 35(9):1561-7. PubMed ID: 3707617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species differences in the hepatic formation of green pigments following the administration of norethindrone.
    White IN; Boobis AR; Davies DS
    Biochem Pharmacol; 1984 Feb; 33(3):459-64. PubMed ID: 6422948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of acetylenic substituents to derivatives in the rat causing the loss of hepatic cytochrome P-450 and haem.
    White IN
    Biochem J; 1978 Sep; 174(3):853-61. PubMed ID: 728091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
    Johnston JO; Wright CL; Holbert GW; Benson HD
    J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 10-(2-propynyl)-estr-4-ene-3,17-dione (MDL 18,962)--a mechanism-based irreversible inhibitor of aromatase--in cultured human foreskin fibroblasts.
    Kruter RH; Berkovitz GD; Migeon CJ; Brown TR
    J Steroid Biochem; 1987 Aug; 28(2):139-45. PubMed ID: 3626551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of liver regeneration on hepatic cytochrome P450 isozymes and serum sex steroids in the male rat.
    Liddle C; Murray M; Farrell GC
    Gastroenterology; 1989 Mar; 96(3):864-72. PubMed ID: 2914647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and endocrine properties of a mechanism-based inhibitor of aromatase.
    Johnston JO; Wright CL; Metcalf BW
    Endocrinology; 1984 Aug; 115(2):776-85. PubMed ID: 6745181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological characterization of 10-(2-propynyl) estr-4-ene-3, 17-dione (MDL 18,962), an enzyme-activated inhibitor of aromatase.
    Johnston JO
    Steroids; 1987; 50(1-3):105-20. PubMed ID: 2847370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of peripheral aromatization in baboons by an enzyme-activated aromatase inhibitor (MDL 18,962).
    Longcope C; Femino A; Johnston JO
    Endocrinology; 1988 May; 122(5):2007-11. PubMed ID: 3359974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs).
    Ronis MJ; Ingelman-Sundberg M; Badger TM
    Biochem Pharmacol; 1994 Nov; 48(10):1953-65. PubMed ID: 7986207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats.
    Murray M
    Arch Biochem Biophys; 1988 May; 262(2):381-8. PubMed ID: 3364973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inductive effect of Telazol on hepatic expression of cytochrome P450 2B in rats.
    Wong A; Bandiera SM
    Biochem Pharmacol; 1996 Sep; 52(5):735-42. PubMed ID: 8765471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
    Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.
    Gardner I; Wakazono H; Bergin P; de Waziers I; Beaune P; Kenna JG; Caldwell J
    Carcinogenesis; 1997 Sep; 18(9):1775-83. PubMed ID: 9328175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of cytochrome P450 IIIA2 in male rat liver after dietary vitamin A supplementation.
    Murray M; Cantrill E; Martini R; Farrell GC
    Arch Biochem Biophys; 1991 May; 286(2):618-24. PubMed ID: 1897981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic system.
    Correia MA; Davoll SH; Wrighton SA; Thomas PE
    Arch Biochem Biophys; 1992 Sep; 297(2):228-38. PubMed ID: 1497342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.